COURSE DIRECTOR
Chris C. Fox, M.D.

DESCRIPTION
Neurosurgery Morbidity and Mortality is a conference/course that consists of robust, multidisciplinary and in-depth reviews of select neurosurgical cases. All neurosurgical cases have the potential to be reviewed, in order to ensure we are optimizing patient safety and outcomes to the greatest extent possible. We have several objective patient safety indicators that automatically refer a surgical case to the conference, including unexpected postoperative neurologic deficit, respiratory failure, unplanned return to the operating room, surgical site infection, 30-day readmission, DVT/PE and patient death (even if unrelated to neurosurgical procedure). By including our colleagues from other specialties involved in our shared patients' care, we strive to ensure a well-rounded, multidisciplinary and detailed review of the entire patient experience.  In addition to Consultants, Neurosurgery Morbidity and Mortality conference includes trainees, nurses, and advanced practice providers.

In-Person and Live-Streamed; Monthly on the 1st Monday from 7:00-8:00 a.m.

TARGET AUDIENCE
Nurses, Nurse Practitioners, Physicians, Physician Assistants, Residents Fellows, and Students.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

• Identify optimal patients for neurosurgical treatment.
• Review patient experiences, outcomes and treatment options.
• Design optimal treatment plans, as well as management of complications.
• Assess complex patient presentations, radiographs including CT, MR, x-rays.

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s):
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

All relevant financial relationships have been mitigated.

COURSE DIRECTOR/PLANNING COMMITTEE:
Relevant financial relationship(s) with ineligible companies:
Chris C. Fox, M.D. - Honoraria - MainStay Medical, Inc.; Stock Equity - Hyperion Surgical, Von Vascular

No relevant financial relationship(s) with ineligible companies:
Olu O. Akinduro, M.D.
Richard W. Byrne, M.D.
Maryna Kol'Tyakova (Coordinator)
Bethany I. Wheeles (Coordinator)

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

SPEAKER POOL 2025:
Relevant financial relationship(s) with ineligible companies:

Ian A. Buchanan, M.D.	Consultant	Medtronic
Eric W. Nottmeier, M.D.	Consultant	Royalties-Globus Spine, Symergy
	Stock Shareholder	Mirus Spine, Track X
Stephen M. Pirris, M.D.	Consultant	Arthrex
	Stock Shareholder	NexSIS, Fibrobiologics, ORHub (HippoFi)
Alfredo Quinones-Hinojosa, M.D.	Consultant	Myosin Therapeutics, Inc.; IP - Skysong Innovations, LLC (fka Arizona Technology Enterprises LLC (AzTE)); Applied Biological Materials, Inc. (ABM); AquaLux Bio, Inc.; Hong Qin
	Stock Shareholder Full/Part-time Employee	Q Scrubs
	Full/Part-time Employee	AquaLux Bio, Inc.; RecurX Bio; Q Scrubs; Dome Therapeutics

No relevant financial relationship(s) with ineligible companies:

Richard D. Beegle, M.D.	Victoria E. Clark, MD, PhD	Juan Pablo Navarro Garcia de Llano	Johnny S. Sandhu, M.D.
Alok A. Bhatt, M.D.	William D. Freeman, M.D.	Jeet Patel, M.D.	Neetu Soni, M.B.B.S., M.D.
Kaisorn L. Chaichana, M.D.	Thien Huynh, M.D.	Vishal N. Patel, M.D., Ph.D.
Selby G. Chen, M.D.	John V. Murray JR, M.D.	Adrian Safa, M.B.B.S.

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

CE Broker Code: 25R00823

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

QUESTIONS?
Contact Maryna Kol'Tyakova